APA (7th ed.) Citation

Okuda, H., Hosomi, S., Itani, S., Kurimoto, N., Kobayashi, Y., Nakata, R., . . . Fujiwara, Y. (2023). Pretreatment serum monocyte chemoattractant protein‐1 as a predictor of long‐term outcome by ustekinumab in patients with Crohn's disease. Journal of gastroenterology and hepatology, 38(6), 910-920. https://doi.org/10.1111/jgh.16151

Chicago Style (17th ed.) Citation

Okuda, Hiroaki, et al. "Pretreatment Serum Monocyte Chemoattractant Protein‐1 as a Predictor of Long‐term Outcome by Ustekinumab in Patients with Crohn's Disease." Journal of Gastroenterology and Hepatology 38, no. 6 (2023): 910-920. https://doi.org/10.1111/jgh.16151.

MLA (9th ed.) Citation

Okuda, Hiroaki, et al. "Pretreatment Serum Monocyte Chemoattractant Protein‐1 as a Predictor of Long‐term Outcome by Ustekinumab in Patients with Crohn's Disease." Journal of Gastroenterology and Hepatology, vol. 38, no. 6, 2023, pp. 910-920, https://doi.org/10.1111/jgh.16151.